Harold E. Brakewood - Mar 31, 2023 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Chief Business Officer
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Harold E. Brakewood
Stock symbol
IMRX
Transactions as of
Mar 31, 2023
Transactions value $
$0
Form type
4
Date filed
4/3/2023, 04:54 PM
Previous filing
Apr 3, 2023
Next filing
Feb 9, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Stock Option Award $0 +165K $0.00 165K Mar 31, 2023 Class A Common Stock 165K $9.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 25% of the underlying shares on January 23, 2024 and then in equal monthly installments over the subsequent three years, subject to Mr. Brakewood's continued employment through each applicable vesting date.